Inducing apoptosis in acute myeloid leukemia; mechanisms and limitations

Acute myeloid leukemia is the expansion of leukemic stem cells which might originate from a stem cell or a progenitor which has acquired self-renewal capacity. An aggregation of leukemic blasts in bone marrow, peripheral blood, and extramedullary tissue will result in acute myeloid leukemia. The mai...

Full description

Saved in:
Bibliographic Details
Main Authors: Zahra Koolivand, Farbod Bahreini, Elham Rayzan, Nima Rezaei
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024173860
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841526191204335616
author Zahra Koolivand
Farbod Bahreini
Elham Rayzan
Nima Rezaei
author_facet Zahra Koolivand
Farbod Bahreini
Elham Rayzan
Nima Rezaei
author_sort Zahra Koolivand
collection DOAJ
description Acute myeloid leukemia is the expansion of leukemic stem cells which might originate from a stem cell or a progenitor which has acquired self-renewal capacity. An aggregation of leukemic blasts in bone marrow, peripheral blood, and extramedullary tissue will result in acute myeloid leukemia. The main difficulty in treating acute myeloid leukemia is multidrug resistance, leading to treatment failure. This unfortunate phenomenon is practically elevated because of apoptosis inhibition in tumor cells.Two general apoptotic pathways are the Bcl-2 regulated pathway (the intrinsic pathway) and the death receptor pathway. Deficiencies in each of these apoptotic pathways can cause the usual resistance mechanism in this disease. This article reviews and highlights different antiapoptotic pathways, currently-used treatments, and new findings in this field, which may lead to the development of treatment methods for acute myeloid leukemia.
format Article
id doaj-art-4ba44818537e4cf2be4c19046ffe534f
institution Kabale University
issn 2405-8440
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj-art-4ba44818537e4cf2be4c19046ffe534f2025-01-17T04:51:01ZengElsevierHeliyon2405-84402025-01-01111e41355Inducing apoptosis in acute myeloid leukemia; mechanisms and limitationsZahra Koolivand0Farbod Bahreini1Elham Rayzan2Nima Rezaei3Faculty of Pharmacy and Pharmaceutical Sciences, Islamic Azad University, Tehran Medical Sciences University (IAUTMU), Tehran, Iran; International Hematology/Oncology of Pediatrics Experts (IHOPE), Universal Scientific Education and Research Network (USERN), Tehran, IranDepartment of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran; Institute of Anatomy, University of Luebeck, Luebeck, GermanyInternational Hematology/Oncology of Pediatrics Experts (IHOPE), Universal Scientific Education and Research Network (USERN), Tehran, Iran; Research Center for Immunodeficiencies (RCID), Children's Medical Center, Tehran University of Medical Sciences, Tehran, IranNetwork of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran; Research Center for Immunodeficiencies (RCID), Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; Corresponding author. Research Center for Immunodeficiencies, Children's Medical Center, Qarib Street, Tehran, Iran.Acute myeloid leukemia is the expansion of leukemic stem cells which might originate from a stem cell or a progenitor which has acquired self-renewal capacity. An aggregation of leukemic blasts in bone marrow, peripheral blood, and extramedullary tissue will result in acute myeloid leukemia. The main difficulty in treating acute myeloid leukemia is multidrug resistance, leading to treatment failure. This unfortunate phenomenon is practically elevated because of apoptosis inhibition in tumor cells.Two general apoptotic pathways are the Bcl-2 regulated pathway (the intrinsic pathway) and the death receptor pathway. Deficiencies in each of these apoptotic pathways can cause the usual resistance mechanism in this disease. This article reviews and highlights different antiapoptotic pathways, currently-used treatments, and new findings in this field, which may lead to the development of treatment methods for acute myeloid leukemia.http://www.sciencedirect.com/science/article/pii/S2405844024173860Acute myeloid leukemiaBCL2 proteinTreatment failureMultiple drug resistanceApoptosis
spellingShingle Zahra Koolivand
Farbod Bahreini
Elham Rayzan
Nima Rezaei
Inducing apoptosis in acute myeloid leukemia; mechanisms and limitations
Heliyon
Acute myeloid leukemia
BCL2 protein
Treatment failure
Multiple drug resistance
Apoptosis
title Inducing apoptosis in acute myeloid leukemia; mechanisms and limitations
title_full Inducing apoptosis in acute myeloid leukemia; mechanisms and limitations
title_fullStr Inducing apoptosis in acute myeloid leukemia; mechanisms and limitations
title_full_unstemmed Inducing apoptosis in acute myeloid leukemia; mechanisms and limitations
title_short Inducing apoptosis in acute myeloid leukemia; mechanisms and limitations
title_sort inducing apoptosis in acute myeloid leukemia mechanisms and limitations
topic Acute myeloid leukemia
BCL2 protein
Treatment failure
Multiple drug resistance
Apoptosis
url http://www.sciencedirect.com/science/article/pii/S2405844024173860
work_keys_str_mv AT zahrakoolivand inducingapoptosisinacutemyeloidleukemiamechanismsandlimitations
AT farbodbahreini inducingapoptosisinacutemyeloidleukemiamechanismsandlimitations
AT elhamrayzan inducingapoptosisinacutemyeloidleukemiamechanismsandlimitations
AT nimarezaei inducingapoptosisinacutemyeloidleukemiamechanismsandlimitations